Pharmacy Times October 31, 2024
Key Takeaways
- Fred’s BPDCN diagnosis required complex treatment, including the CALGB 8811 protocol and intrathecal chemotherapy, necessitating significant coordination.
- Asparaginase erwinia chrysanthemi was used to treat Fred’s leukemia, highlighting the challenges of accessing uncommon drugs.
- The narrative emphasizes the philosophical belief that every patient matters, underscoring the interconnectedness of healthcare professionals and patients.
- Balancing humility and hubris is crucial in oncology, enabling receptiveness to new ideas and the confidence to enact change.
A patient with BPDCN finds her champion.
“Hi, I’m Fred. I’m a handful.” With those words began one of my most treasured friendships. Fred wasn’t her real name but a nom de plume she liked to use when introducing herself to see how people would...
Today's Sponsors
Today's Sponsor